And it will be interesting to see what csl does in terms of acquiring this new source of supply of blood components. https://www.news-medical.net/news/20200619/Human-trials-to-commence-using-SARS-CoV-2-antibodies-from-cows-blood.aspx
Anti-Ageing, page-4
Featured News
Add CSL (ASX) to my watchlist
|
|||||
Last
$301.12 |
Change
0.350(0.12%) |
Mkt cap ! $145.5B |
Open | High | Low | Value | Volume |
$301.69 | $304.00 | $298.71 | $230.4M | 764.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 32 | $301.10 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$301.13 | 937 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 32 | 301.100 |
1 | 300 | 300.660 |
2 | 2187 | 300.650 |
3 | 496 | 300.000 |
1 | 20 | 299.950 |
Price($) | Vol. | No. |
---|---|---|
301.130 | 937 | 1 |
301.380 | 937 | 1 |
301.620 | 937 | 2 |
301.700 | 100 | 1 |
301.710 | 3830 | 1 |
Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online